CorMedix Inc. announced changes to its executive leadership team. Khoso Baluch is retiring from his role as Chief Executive Officer, effective October 4, 2021. The Board has appointed Matt David, M.D., CorMedix’s EVP and Chief Financial Officer, as interim Chief Executive Officer, effective immediately. Dr. David will continue to hold his position of Chief Financial Officer. Mr. Baluch will serve the Company in an advisory capacity to facilitate a smooth transition.